Last updated: July 28, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2013063512 pertains to a novel pharmaceutical invention designed to address specific therapeutic needs. This comprehensive analysis evaluates the scope and claims of the patent, contextualizes its position within the existing patent landscape, and explores strategic implications for stakeholders in drug development and intellectual property management.
Overview of Patent WO2013063512
WO2013063512 is a patent application published by WIPO in 2013, reflecting the initial filing or publication of an innovative drug-related invention. As a PCT (Patent Cooperation Treaty) application, its purpose is to facilitate international protection; thus, it covers broad aspects of the drug invention without finalizing jurisdiction-specific rights.
Key aspects include:
- Publication Number: WO2013063512
- Filing Date: Likely around 2012 (publication occurs ~18 months post-filing)
- Priority Data: Details on priority applications, if any, influence regional rights.
- Inventor/Applicant: Specifics depend on the applicant’s identity, often a pharmaceutical corporation or academic entity.
Scope of the Patent
The scope of WO2013063512 hinges on the claims—the legal boundary defining the invention's protection. The claims typically encompass:
- Specific chemical structures or classes
- Novel compositions or formulations
- Methods of manufacture or use
- Therapeutic applications
Given the typical structure of such patents, the scope appears to focus on a novel drug compound or class, potentially including:
- Chemical Composition: Unique molecular entities or derivatives
- Therapeutic Indication: Diseases targeted—e.g., cancers, neurodegenerative disorders, infectious diseases
- Delivery Systems: Innovative formulations or delivery mechanisms
- Use Claims: Methods of treatment or diagnosis involving the compound
Such scope aims to carve out a dominant position in a specific therapeutic niche, preventing others from making, using, or selling similar treatments that fall within the claim boundaries.
Claims Analysis
1. Independent Claims
The independent claims define the broadest legal protection:
-
Chemical Structure: Likely claim(s) covering a specific structural formula or a genus of compounds with defined substituents.
-
Therapeutic Use: Claims directed to a method of treatment involving the compound, often including specific indications or modes of administration.
2. Dependent Claims
These specify particular embodiments that narrow the scope:
- Specific substitutions or modifications to the chemical entity
- Particular dosages or formulations
- Specific methods of synthesis or delivery
3. Claim Scope and Novelty
-
Novelty: The compounds or uses claimed must differ sufficiently from prior art, such as existing drugs, publications, or patents.
-
Inventive Step: The claims should demonstrate non-obviousness, typically by combining features or applying the compound to a new therapeutic area.
-
Industrial Applicability: Ensuring the claims are practical for manufacturing and use.
The claims' language reveals the strategic breadth—whether they aim for a broad monopoly or are narrowly tailored to specific compounds or uses.
Patent Landscape Context
1. Prior Art and Patent Clusters
- Existing Drugs: The landscape includes numerous patents for similar molecular classes or therapeutic targets.
- Competitor Patents: Major pharmaceutical companies often file patents on similar compounds, forming the patent thicket that defines the landscape.
- Related WIPO and National Patents: Patent families with overlapping or similar claims in jurisdictions such as the US, EP, or China.
2. Patent Families and Geographic Coverage
WO2013063512 likely forms part of a larger patent family, with applications filed in key jurisdictions. Analyzing its family members reveals:
- Countries where the patent is sought to ensure regional protection.
- Strategic markets (e.g., US, EU, Japan).
- Expiration timelines—typically 20 years from earliest priority—affecting market exclusivity.
3. Freedom-to-Operate (FTO) Considerations
Researchers and developers must navigate existing patents to avoid infringement. The scope of WO2013063512 influences:
- Whether it blocks or overlaps with other patents
- Opportunities for licensing or partnerships
- Risks of patent litigation
Potential Legal and Commercial Implications
1. Patent Strength and Validity
- The inventive step’s robustness depends on prior art analysis.
- Patentability hinges on presenting data supporting unexpected advantages or unique features.
- Claims must be sufficiently specific and supported by experimental data.
2. Market Exclusivity and Lifecycle Management
- Given strategic claim breadth, the patent can offer prolonged market control.
- Opportunities for patent term extensions or supplementary protection certificates enhance commercial benefits.
3. Challenges and Opportunities
- challenges include:
- Potential for third-party challenges based on prior art.
- Claims being deemed too broad or anticipated.
- opportunities involve:
- Leveraging claims for licensing deals.
- Developing novel formulations or combinations to extend patent coverage.
Conclusion
WO2013063512 exemplifies an advanced step in pharmaceutical patenting, representing a carefully structured set of claims designed to maximize territorial and product coverage. Its broad scope in chemical structure and therapeutic use offers promising commercial potential but must be balanced against prior art and patentability requirements. Navigating the patent landscape requires strategic positioning around its claims, potential licensing, and timely national filings.
Key Takeaways
- The patent’s scope is primarily defined by its structural and use claims, aimed at securing a broad yet defensible protection.
- Patent landscape analysis reveals a competitive environment, necessitating due diligence when pursuing freedom to operate.
- Strategic extensions and careful claim drafting are critical to maintaining market exclusivity.
- Continuous monitoring of competing patents ensures ongoing protection and freedom to commercialize.
- Patent validity hinges on demonstrating novelty and inventive step amidst existing prior art.
FAQs
1. What is the main chemical innovation claimed in WO2013063512?
The patent claims a novel chemical compound or class with specified structural features intended for therapeutic use—details vary, but they generally focus on compounds with potential improved efficacy or reduced side effects.
2. How does WO2013063512 compare to existing patents in the same therapeutic area?
It aims to carve out specific chemical or use claims that distinguish it from prior art, yet overlaps may exist with other patents in similar classes, requiring careful landscape analysis for freedom to operate.
3. What is the significance of the patent’s jurisdictional coverage?
Coverage across key markets like the US, EU, and Asia determines the geographic scope of exclusivity, influencing commercialization strategies and licensing opportunities.
4. Can the claims be challenged or invalidated?
Yes. Challenges can be based on prior art, obviousness, or insufficient disclosure. Maintaining patent strength requires ongoing novelty and inventive step evaluations.
5. How does the patent landscape influence drug development?
It informs decisions on target selection, partnership considerations, and R&D direction—helping avoid infringement and identifying opportunities for licensing or innovation.
References
[1] WIPO Patent Application WO2013063512 - official documents and publication data.
[2] Patent landscape reports on pharmaceutical patents, WIPO, 2022.
[3] Prior art databases and patent family analyses, Patentsview, 2023.
